Marvel Biosciences Corp (MRVL) — Net Asset Momentum
Marvel Biosciences Corp (MRVL) recorded a net asset momentum of -41.8% as of July 2025, with net assets of CA$-4.01 Million CAD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Marvel Biosciences Corp (MRVL) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Marvel Biosciences Corp Net Asset Momentum (2020–2025)
This chart tracks Marvel Biosciences Corp's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -41.8%, with net assets of CA$-4.01 Million CAD as of July 2025. For live market cap and overall valuation, see Marvel Biosciences Corp (MRVL) market capitalisation.
Annual Net Asset History for Marvel Biosciences Corp (2020–2025)
The table below shows the complete annual net asset history for Marvel Biosciences Corp from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Marvel Biosciences Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CAD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CA$-4.01 Million | CA$326.71K | CA$4.33 Million | ▼ -41.8% |
| 2024 | CA$-2.83 Million | CA$491.31K | CA$3.32 Million | ▼ -64.3% |
| 2023 | CA$-1.72 Million | CA$672.39K | CA$2.39 Million | ▼ -979.7% |
| 2022 | CA$195.54K | CA$913.54K | CA$718.00K | ▼ -91.7% |
| 2021 | CA$2.36 Million | CA$2.47 Million | CA$112.48K | ▲ +1882.8% |
| 2020 | CA$118.80K | CA$295.99K | CA$177.18K | — |